Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,678.00    -42.00 (-1.13%)
Bid:
3,702.00
Ask:
3,706.00
Spread: 4.00 (0.108%)
Market Cap: £1.03b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Result of AGM

21 May 2025 13:02

RNS Number : 6377J
4imprint Group PLC
21 May 2025
 

21 May 2025

 

4imprint Group plc

Results of Annual General Meeting 2025

 

All of the resolutions proposed at the Annual General Meeting of 4imprint Group plc ("4imprint") held at 11.00 a.m. on Wednesday 21 May 2025 were duly passed and the results of the poll on all resolutions passed at the AGM are set out in the table below.

 

Each Shareholder, present in person or by proxy, was entitled to one vote per share held.

 

FOR*

%

AGAINST

%

WITHHELD**

1

Receipt of Financial Statements

22,212,955

99.99

279

0.01

502,074

2

Directors' Remuneration Report

21,625,338

95.21

1,088,575

4.79

1,395

3

Approval of final dividend

22,715,296

100.00

0

0.00

12

4

Approval of special dividend

22,715,296

100.00

0

0.00

12

5

Re-election of Director - Lindsay Claire Beardsell

22,482,813

98.98

231,420

1.02

1,074

6

Election of Director - Michelle Marie Brukwicki

22,413,042

98.68

300,953

1.32

1,313

7

Re-election of Director - John Michael Gibney

22,039,920

97.05

670,817

2.95

4,570

8

Re-election of Director - Kevin Lyons-Tarr

22,461,995

98.90

248,743

1.10

4,570

9

Re-election of Director - Paul Stephen Moody

21,738,424

95.72

972,314

4.28

4,570

10

Re- election of Director - Jaz Rabadia Patel

22,479,317

98.98

231,420

1.02

4,570

11

Re-election of Director - Christina Dawn Southall

22,142,823

97.50

567,914

2.50

4,570

12

Re-appointment of Auditors

22,227,767

99.99

1,051

0.01

486,490

13

Remuneration of Auditors

22,712,572

99.99

1,634

0.01

1,102

14

Directors' authority to allot shares

22,352,386

98.42

358,581

1.58

4,341

15

Disapplication of Pre-emption rights***

22,490,294

99.03

220,285

0.97

4,729

16

Authority to purchase own shares***

22,701,723

99.99

650

0.01

12,935

17

Notice of General Meeting***

21,964,312

96.70

750,603

3.30

393

 

* Includes discretionary votes. 

 ** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

 *** Indicates Special Business.

 

The total number of Ordinary Shares in issue, excluding Treasury Shares, on 21 May 2025 is 28,172,530. 

 

A copy of the resolutions passed as special business at today's Annual General Meeting will, in accordance with Listing Rule 9.6.2, be submitted to the National Storage Mechanism.

 

 

Emma Taylor

Company Secretary

4imprint Group plc

Tel: + 44 (0) 20 3709 9680

E-mail: agm@4imprint.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUARURVAUVUAR
Date   Source Headline
9th Jun 20261:58 pmRNSHolding(s) in Company
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.